Followers | 16 |
Posts | 2067 |
Boards Moderated | 0 |
Alias Born | 02/28/2011 |
Wednesday, August 31, 2016 11:59:13 PM
https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001335002&type=&dateb=&owner=include&count=40
SIC: 7372 - SERVICES-PREPACKAGED SOFTWARE
State location: NV | State of Inc.: FL | Fiscal Year End: 0731
(Assistant Director Office: 3)
Get insider transactions for this issuer.
Business Address
3030 SOUTH JONES BOULEVARD #101
LAS VEGAS NV 89146
949-945-8069
Mailing Address
3030 SOUTH JONES BOULEVARD #101
LAS VEGAS NV 89146
https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001335002&type=&dateb=&owner=include&count=40
Commercial Registered Agent:
TAKOS LAW, LTD.
1980 FESTIVAL PLAZA DR STE 300
LAS VEGAS, NV 89135
Phone: 702-856-4629
http://nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=l7SbU05tg0G0K4sioxeh0A%253d%253d&nt7=0
President, Secretary, Treasurer, Director, CEO, CFO, Sole Officer - SHAUN IRVINE
1770 XIMENO AVE. #104
LONG BEACH, CA 90815
or
591 HILL TOP, UNIT 21
REDDING, CA 96003
or
3569 SAGITTARIUS DR.
LAS VEGAS, NV 89135
http://nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=l7SbU05tg0G0K4sioxeh0A%253d%253d&nt7=0
Exobox Stock Transfer Agent:
Action Stock Transfer Corporation
2469 E. Fort Union Boulevard, Suite 214
Salt Lake City, UT 84121
Telephone: (801) 274-1088
Email: info@actionstocktransfer.com
Website: http://www.actionstocktransfer.com
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM